DelveInsight’s “Postoperative Ileus Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Postoperative Ileus, historical and forecasted epidemiology as well as the Postoperative Ileus market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Postoperative Ileus market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Postoperative Ileus Market Forecast
Some of the key facts of the Postoperative Ileus Market Report:
- The Postoperative Ileus market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
- Postoperative ileus (POI) is a condition that increases patient morbidity, prolongs hospital stays, and raises healthcare expenses. With an incidence of 10-27%, POI is regarded as a serious consequence for patients after abdominal surgery and is a common problem for abdominal surgeons
- According to a study, 2.7 million of the 22 million inpatient surgical procedures carried out annually in the United States result in POI that last more than one day. ICD-9 data from 2002 were reviewed retrospectively, and more than 800,000 surgical patients in the US had an ileus rate of 4.3%
- Key Postoperative Ileus Companies: Palisade Bio, Bausch Health Americas, Inc., Tsumura USA, Cubist Pharmaceuticals LLC, Progenics Pharmaceuticals, Inc., Norgine, ChironWells GmbH, Leading BioSciences Inc, Orexa B.V., RaQualia Pharma Inc., Takeda Pharmaceutical Co. Ltd., Yuhan Corp., and others
- Key Postoperative Ileus Therapies: LB1148, Methylnaltrexone, Daikenchuto, Alvimopan, MOA-728, TZP-101, and others
- The Postoperative Ileus epidemiology based on gender analyzed that postoperative ileus is more common in males than females
- The Postoperative Ileus market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Postoperative Ileus pipeline products will significantly revolutionize the Postoperative Ileus market dynamics.
Postoperative Ileus Overview
The impairment of gastrointestinal (GI) motility following intra-abdominal or non-abdominal surgery is known as postoperative ileus (POI). Food passes from the mouth through the pharynx (throat), oesophagus, stomach, small and large intestines, and out of the body, which is referred to as GI motility.
Get a Free sample for the Postoperative Ileus Market Report
https://www.delveinsight.com/sample-request/postoperative-ileus-market
Postoperative Ileus Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Postoperative Ileus Epidemiology Segmentation:
The Postoperative Ileus market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Postoperative Ileus
- Prevalent Cases of Postoperative Ileus by severity
- Gender-specific Prevalence of Postoperative Ileus
- Diagnosed Cases of Episodic and Chronic Postoperative Ileus
Download the report to understand which factors are driving Postoperative Ileus epidemiology trends @ Postoperative Ileus Epidemiology Forecast
Postoperative Ileus Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Postoperative Ileus market or expected to get launched during the study period. The analysis covers Postoperative Ileus market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Postoperative Ileus Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Postoperative Ileus Therapies and Key Companies
- LB1148: Palisade Bio
- Methylnaltrexone: Bausch Health Americas, Inc.
- Daikenchuto: Tsumura USA
- Alvimopan: Cubist Pharmaceuticals LLC
- MOA-728: Progenics Pharmaceuticals, Inc.
- TZP-101: Norgine
Discover more about therapies set to grab major Postoperative Ileus market share @ Postoperative Ileus Treatment Market
Scope of the Postoperative Ileus Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Postoperative Ileus Companies: Palisade Bio, Bausch Health Americas, Inc., Tsumura USA, Cubist Pharmaceuticals LLC, Progenics Pharmaceuticals, Inc., Norgine, ChironWells GmbH, Leading BioSciences Inc, Orexa B.V., RaQualia Pharma Inc., Takeda Pharmaceutical Co. Ltd., Yuhan Corp., and others
- Key Postoperative Ileus Therapies: LB1148, Methylnaltrexone, Daikenchuto, Alvimopan, MOA-728, TZP-101, and others
- Postoperative Ileus Therapeutic Assessment: Postoperative Ileus current marketed and Postoperative Ileus emerging therapies
- Postoperative Ileus Market Dynamics: Postoperative Ileus market drivers and Postoperative Ileus market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Postoperative Ileus Unmet Needs, KOL’s views, Analyst’s views, Postoperative Ileus Market Access and Reimbursement
To know more about Postoperative Ileus companies working in the treatment market, visit @ Postoperative Ileus Clinical Trials and Therapeutic Assessment
Table of Contents
1. Postoperative Ileus Market Report Introduction
2. Executive Summary for Postoperative Ileus
3. SWOT analysis of Postoperative Ileus
4. Postoperative Ileus Patient Share (%) Overview at a Glance
5. Postoperative Ileus Market Overview at a Glance
6. Postoperative Ileus Disease Background and Overview
7. Postoperative Ileus Epidemiology and Patient Population
8. Country-Specific Patient Population of Postoperative Ileus
9. Postoperative Ileus Current Treatment and Medical Practices
10. Postoperative Ileus Unmet Needs
11. Postoperative Ileus Emerging Therapies
12. Postoperative Ileus Market Outlook
13. Country-Wise Postoperative Ileus Market Analysis (2019–2032)
14. Postoperative Ileus Market Access and Reimbursement of Therapies
15. Postoperative Ileus Market Drivers
16. Postoperative Ileus Market Barriers
17. Postoperative Ileus Appendix
18. Postoperative Ileus Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email:Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services
